12:00 AM
 | 
Jul 19, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

BioDiem, Serum Institute of India sales and marketing update

Serum Institute launched BioDiem's NasoVac live attenuated influenza vaccine (LAIV) against swine influenza A (H1N1) in India. Serum Institute has a sublicense to the vaccine under the World Health Organization's Pandemic Flu program. Nobilon International B.V., a unit...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >